Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells
Authors
Keywords
-
Journal
LEUKEMIA
Volume 28, Issue 5, Pages 1081-1091
Publisher
Springer Nature
Online
2013-10-29
DOI
10.1038/leu.2013.316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability
- (2013) Bryan King et al. CELL
- Origins of aberrant DNA methylation in acute myeloid leukemia
- (2013) T Schoofs et al. LEUKEMIA
- In focus: MLL-rearranged leukemia
- (2013) J de Boer et al. LEUKEMIA
- Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia
- (2013) E H Estey LEUKEMIA
- The MLL recombinome of acute leukemias in 2013
- (2013) C Meyer et al. LEUKEMIA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells
- (2013) J T Lynch et al. Cell Death & Disease
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- c-Myc Is a Universal Amplifier of Expressed Genes in Lymphocytes and Embryonic Stem Cells
- (2012) Zuqin Nie et al. CELL
- Transcriptional Amplification in Tumor Cells with Elevated c-Myc
- (2012) Charles Y. Lin et al. CELL
- The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
- (2012) J Shi et al. ONCOGENE
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- Regulation of gene transcription by the oncoprotein MYC
- (2011) Bernhard Lüscher et al. GENE
- The heterogeneity of pediatric MLL-rearranged acute myeloid leukemia
- (2011) B V Balgobind et al. LEUKEMIA
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Structure and nucleosome interaction of the yeast NuA4 and Piccolo–NuA4 histone acetyltransferase complexes
- (2011) Johnathan R Chittuluru et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
- (2010) Maria E. Figueroa et al. CANCER CELL
- A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs
- (2010) Jonghwan Kim et al. CELL
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- (2010) S. A. Forbes et al. NUCLEIC ACIDS RESEARCH
- MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation
- (2009) M. E. Figueroa et al. BLOOD
- Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells
- (2009) Tim C.P. Somervaille et al. Cell Stem Cell
- The ups and downs of Myc biology
- (2009) Laura Soucek et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma
- (2009) Shingo Nakahata et al. GENES CHROMOSOMES & CANCER
- Enhancer of Polycomb1 Acts on Serum Response Factor to Regulate Skeletal Muscle Differentiation
- (2009) Ju-Ryoung Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial
- (2009) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Distinct Thresholds Govern Myc's Biological Output In Vivo
- (2008) Daniel J. Murphy et al. CANCER CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started